R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2024
Back to search
Official data from USPTO
LYMPHOMAP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LYMPHOMAP
ST13
US500000090523038Class
9, 35, 38, 42, 44
Filing
90523038
Registration
7355878
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/10/2024
Trademark type
Word
Nice classes
9, 35, 38, 42, 44
Filing date
02/10/2021
Registration date
04/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
04/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/21/2022
First use in commerce
11/24/2022
Drawing code
4
Owner type
03
Owner location
Long Island City, NY, US
Examiner
FIONDA, LAURA ELIZABETH
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
LYMPHOMAP Inc.
LYMPHOMAP, Inc.
Representatives
Ranjini Acharya PILLSBURY WINTHROP SHAW PITTMAN LLP
Technical classification
Nice Classes
Class 9Class 35Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer programs using artificial intelligence for use in software development and machine learning in the field of healthcare; Recorded computer software using artificial intelligence for use in software development and machine learning in the field of healthcare; Software as a Medical Device (SaMD)downloadablefor diagnosing and treating cancer; Software as a Medical Device (SaMD)recordedfor diagnosing and treating cancer
Class 35
Business collaboration servicesproviding a national computer-based networking web site for health care and medical researchers and educators to collaborate across disciplines to help improve health care education and medical education; Promoting collaboration within the scientificresearch and medical communities to achieve advances in the field of healthcare; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Providing an on-line database providing business intelligence in the fields of medical devicespharmaceuticals and life sciences
Class 38
Videoconferencing services
Class 42
Application service provider (ASP) featuring software using artificial intelligence for use in software development and machine learning in the field of healthcare; Medical and scientific research in the field of cancer treatment and diagnosis; Providing online non-downloadable computer programs for use in cancer diagnosis; Providing a website featuring non-downloadable software using artificial intelligence for use in software development and machine learning in the field of healthcare; Providing information about medical and scientific research via a website; Providing on-line non-downloadable software using artificial intelligence for use in cancer treatment and diagnosis; Software as a service (SAAS) services featuring software using artificial intelligence for use in cancer treatment and diagnosis; Software as a service (SAAS) services featuring software using artificial intelligence for use in software development and machine learning in the field of healthcare; Technology consultation in the field of artificial intelligence
Class 44
Medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; Providing a website featuring information in the field of the diagnosis and treatment of cancer; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processedexchanged and accessed in real-time by users; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions
Publications
History of USPTO decisions and trademark events.
35 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/09/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/07/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2024
ALIE
ASSIGNED TO LIE
03/05/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/13/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/17/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2023
GNRT
NON-FINAL ACTION E-MAILED
02/22/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/22/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/10/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/09/2023
IUAF
USE AMENDMENT FILED
12/08/2022
EISU
TEAS STATEMENT OF USE RECEIVED
12/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/27/2022
EX1G
SOU EXTENSION 1 GRANTED
05/25/2022
EXT1
SOU EXTENSION 1 FILED
05/25/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/25/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/14/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/19/2021
PUBO
PUBLISHED FOR OPPOSITION
10/19/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/29/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
09/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
09/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/11/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/11/2021
GNRT
NON-FINAL ACTION E-MAILED
09/11/2021
CNRT
NON-FINAL ACTION WRITTEN
09/11/2021
DOCK
ASSIGNED TO EXAMINER
09/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/14/2021
NWAP
NEW APPLICATION ENTERED
02/15/2021
Continuous trademark protection
Get notified about every new filing that threatens LYMPHOMAP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.